BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Hepion Pharmaceuticals Inc.

Headquarters: Edison, NJ, United States of America
Year Founded: 2013
Status: Public
Industry Sector: HealthTechnology
CEO: John Patrick Brancaccio, CPA
Number Of Employees: 22
Enterprise Value: $-16,308
PE Ratio: -0.01
Exchange/Ticker 1: NASDAQ:HEPA
Exchange/Ticker 2: N/A
Latest Market Cap: $518,200

BioCentury | May 22, 2023
Deals

May 22 Quick Takes: Ironwood building GI franchise via $1B VectivBio acquisition

Plus: Krystal raises $160M PIPE and updates from Avrobio-Novartis, Avidity, BMS, Hepion, Rain, Blueprint 
BioCentury | Aug 12, 2017
Product Development

HBV test kitchen

How far industry is from assembling a functional cure in HBV
BioCentury | Apr 28, 2017
Clinical News

Tenofovir exalidex: Interim Ph IIa data

BioCentury | Apr 27, 2017
Financial News

ContraVir completes follow-on

Items per page:
1 - 4 of 4